By 2050, it is estimated that the number of people older than 65 years will rise to approximately 1.5 billion, representing 16% of the world population.
In Australia and other developed countries, such as the United States and the UK, a similar trend has been observed. 2 In Australia, the proportion of the population aged 65 years and over has increased from 10.5% in 1986 to 14.0% in 2011. This ageing population has produced an increased demand on the healthcare system. Eight per cent of Australians aged 65 years and older receive either permanent or respite residential aged care services. 3 Older adults residing in aged care facilities (RACFs) are often diagnosed with multiple chronic diseases and require multiple medications to manage their health-related conditions. The international literature suggests that up to 91% of aged care residents take at least 5 regular medicines (also generally known as polypharmacy 4, 5 ) and 65% take more than 10 regular medicines (described as hyperpolypharmacy) every day. 6 Polypharmacy places residents at higher risk of drug interactions, adverse drug reactions and medication errors, and increases morbidity, mortality and complexity of care.
7
There is an urgent need for interventions and developing new models of care to address medication safety in aged care. The objective of this study was to demonstrate the need for an innovative model of care involving pharmacists being placed into RACFs.
| COMMENT
It has been shown that RACF consultations by general practitioners (GPs) differ significantly from those managed in general practice.
RACF consultations often involve managing chronic medical conditions. Indeed, a study of GP consultations in Australia at RACFs showed that conditions more often encountered compared with general practice included dementia, urinary tract infections, diabetes, heart failure, osteoarthritis, stroke, chronic skin ulcers, chronic cies, coordinate the transition-of-care and conduct on-site medication reviews to improve the quality use of medicines to minimize medication-related problems. In a recent study, 15 health professionals, along with health policy and consumer representatives, identified a number of priority interventions to manage polypharmacy in RACFs. The six specific interventions identified were as follows:
"implementation of a pharmacist-led medication reconciliation service for new residents," "conduct facility level audits and feedback to staff and healthcare professionals," "develop deprescribing scripts to assist clinician-resident discussion," "develop or revise prescribing guidelines specific to older people with multimorbidity in RACFs,"
"implement electronic medication charts and records" and "better support Medication Advisory Committees to address medication appropriateness". 15 There is accumulating evidence demonstrating beneficial outcomes of pharmacists' interventions in aged care. A systematic review in 2017 investigating studies conducted in Australia, the USA, the UK and a few other European countries reported that medication reviews by pharmacists either working independently or with other healthcare professionals improved the quality use of medicine in RACFs. 16 In addition to improving the quality use of medicines through reducing polypharmacy and medication-related adverse effects, interventions by pharmacists have been also reported to incur financial benefits to the healthcare system through avoided hospitalization. 17 Pharmacists' interventions to reduce polypharmacy are supported by many studies, including a recent cluster randomized controlled trial involving 59 Dutch RACFs that reported that a multidisciplinary systematic medication review conducted by pharmacists with medical doctors successfully decreased inappropriate medication use without a decline in residents' well-being. 18 Overall, pharmacists have been shown to improve the safe and effective use of medications in RACFs when they provide services on a visiting basis; however, it seems that no study has assessed the effectiveness of having a pharmacist based in the RACF on a part-time or full-time basis.
| WHAT IS NE W AND CON CLUS I ON
Despite the positive evidence for pharmacists' interventions in aged care, to our knowledge, there is no report or evaluation of a healthcare model that integrates on-site pharmacists into RACFs in the international literature. Therefore, we have commenced a pilot trial 19 integrating a non-dispensing pharmacist into a RACF to assess the impact on the quality use of medications.
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